Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemia.
Yang Y, Liu Y, Sun H, Meng L, Lin H, Chen C, Hu J, Shen X, Duan M, Zhang Y, Abulaiti D, Wang J, Zhu H, Hua L, Leng Q, Zhang C, Sun L, Li W, Zhu H, Liu B, Wang J.
Yang Y, et al. Among authors: abulaiti d.
Haematologica. 2024 Dec 1;109(12):3965-3974. doi: 10.3324/haematol.2023.284892.
Haematologica. 2024.
PMID: 38934064
Free PMC article.